MGTX (MGTX) Stock Price & Analysis
MGTX (MGTX) fell 0.57% to USD 13.89 as of September 8, 2026 at 10:17 UTC, according to Nexqual real-time market data.
MGTX last closed at USD 13.89; the session ranged USD 13.6–14.04 on volume of 531,145 shares. Market capitalization is —, with a 52-week range of USD 6.62–15.35 (NMS). Source: Nexqual, September 8, 2026 at 10:17 UTC.
Key Statistics (as of September 8, 2026 at 10:17 UTC)
| Price | USD 13.89 |
|---|---|
| Change | ▼ 0.57% (down) |
| Previous Close | USD 13.89 |
| Open | USD 13.89 |
| Day Range | USD 13.6 – 14.04 |
| 52-Week Range | USD 6.62 – 15.35 |
| Volume | 531,145 shares |
| Market Cap | — |
| Exchange | NMS |
Technical Analysis (MGTX)
Nexqual's technical model rates MGTX "BUY" based on 4 bullish and 1 bearish signals across 128 daily candles, as of September 8, 2026 at 10:17 UTC.
| Overall Signal | BUY |
|---|---|
| RSI (14) | 52.72 (neutral) |
| vs SMA50 | Above (USD 13.18) |
| MACD | 0.36 (positive) |
From MGTX's Latest SEC 10-K Filing (filed 2026-03-30)
Source: SEC EDGAR 10-K. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| RGNX | REGENXBIO Inc. | USD 8.94 | ▼ 6.88% |
| STOK | Stoke Therapeutics, Inc. | USD 29.81 | ▼ 2.26% |
| CRNX | Crinetics Pharmaceuticals, Inc. | USD 84.95 | ▲ 0% |
| VYGR | Voyager Therapeutics, Inc. | USD 3.51 | ▼ 0.85% |
| SLDB | Solid Biosciences Inc. | USD 10.25 | ▼ 0.34% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: September 8, 2026 at 10:17 UTC. This page is informational and not investment advice.